| abstract |
Pharmaceutical form for parenteral administration, comprising: -as the active substance dronedarone or one of its pharmaceutically acceptable salts, -physiologically acceptable buffer solution capable of maintaining a pH solution between 3 and 5, -physiologically acceptable and water-soluble β-cyclodextrin derivative. The application contains another 18 patent claims. |